MEI Pharma Statistics
Total Valuation
MEI Pharma has a market cap or net worth of $14.33 million. The enterprise value is -$9.15 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MEI Pharma has 6.66 million shares outstanding.
Current Share Class | 6.66M |
Shares Outstanding | 6.66M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.29% |
Owned by Institutions (%) | 16.03% |
Float | 4.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.66 |
P/TBV Ratio | 0.66 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.66
Current Ratio | 10.66 |
Quick Ratio | 10.38 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.69% and return on invested capital (ROIC) is -33.73%.
Return on Equity (ROE) | -93.69% |
Return on Assets (ROA) | -30.67% |
Return on Invested Capital (ROIC) | -33.73% |
Return on Capital Employed (ROCE) | -114.30% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.36M |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.50% in the last 52 weeks. The beta is 0.63, so MEI Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | -44.50% |
50-Day Moving Average | 2.57 |
200-Day Moving Average | 2.84 |
Relative Strength Index (RSI) | 33.46 |
Average Volume (20 Days) | 8,264 |
Short Selling Information
The latest short interest is 3,543, so 0.05% of the outstanding shares have been sold short.
Short Interest | 3,543 |
Short Previous Month | 5,774 |
Short % of Shares Out | 0.05% |
Short % of Float | 0.07% |
Short Ratio (days to cover) | 0.44 |
Income Statement
Revenue | n/a |
Gross Profit | -10.86M |
Operating Income | -25.26M |
Pretax Income | 26.16M |
Net Income | -38.22M |
EBITDA | -24.68M |
EBIT | -25.26M |
Earnings Per Share (EPS) | -$5.74 |
Full Income Statement Balance Sheet
The company has $23.74 million in cash and n/a in debt, giving a net cash position of $23.74 million or $3.56 per share.
Cash & Cash Equivalents | 23.74M |
Total Debt | n/a |
Net Cash | 23.74M |
Net Cash Per Share | $3.56 |
Equity (Book Value) | 22.10M |
Book Value Per Share | 3.32 |
Working Capital | 22.10M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -36.04M |
Capital Expenditures | n/a |
Free Cash Flow | -36.04M |
FCF Per Share | -$5.41 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MEI Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -261.91% |
FCF Yield | -247.01% |
Dividend Details Analyst Forecast
The average price target for MEI Pharma is $7.00, which is 225.58% higher than the current price. The consensus rating is "Hold".
Price Target | $7.00 |
Price Target Difference | 225.58% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on April 17, 2023. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Apr 17, 2023 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
MEI Pharma has an Altman Z-Score of -19.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -19.32 |
Piotroski F-Score | 2 |